Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa

Marian Loveday, K. Wallengren, A. Voce, B. Margot, T. Reddy, I. Master, James C.M. Brust, K. Chaiyachati, N. Padayatchi

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

SETTING: In KwaZulu-Natal, South Africa, a setting endemic for tuberculosis (TB) and the human immunodeficiency virus (HIV), prolonged hospitalisation for the treatment of the growing number of multidrug-resistant TB (MDR-TB) patients is neither possible nor effective. OBJECTIVE: To compare early treatment outcomes in patients with MDR-TB with and without HIV coi nfection at four decentralised rural sites with a central urban referral hospital. DESIGN: This is an operational, prospective cohort study of patients between 1 July 2008 and 30 November 2009, where culture conversion, time to culture conversion, survival and predictors of these outcomes were analysed. RESULTS: Of 860 patients with MDR-TB, 419 were at the decentralised sites and 441 at the central hospital. Overall, 71% were HIV co-infected. In the 17-month study period, there was a higher proportion of culture conversion at the decentralised sites compared with the centralised hospital (54% vs. 24%, P < 0.001, OR 3.76, 95%CI 2.81-5.03). The median time to treatment initiation was significantly shorter at the decentralised sites compared with the centralised hospital (72 vs. 93 days, P < 0.001). There was no significant difference in survival following treatment initiation. CONCLUSION: In this study, early treatment outcomes suggest that decentralised care for MDR-TB patients is superior to that in a centralised setting.

Original languageEnglish (US)
Pages (from-to)209-215
Number of pages7
JournalInternational Journal of Tuberculosis and Lung Disease
Volume16
Issue number2
DOIs
StatePublished - Feb 1 2012

Fingerprint

South Africa
HIV
Multidrug-Resistant Tuberculosis
Survival
Urban Hospitals
Tuberculosis
Hospitalization
Cohort Studies
Therapeutics
Referral and Consultation
Prospective Studies

Keywords

  • High burden of TB and HIV
  • Operational research

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Infectious Diseases

Cite this

Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa. / Loveday, Marian; Wallengren, K.; Voce, A.; Margot, B.; Reddy, T.; Master, I.; Brust, James C.M.; Chaiyachati, K.; Padayatchi, N.

In: International Journal of Tuberculosis and Lung Disease, Vol. 16, No. 2, 01.02.2012, p. 209-215.

Research output: Contribution to journalArticle

Loveday, Marian ; Wallengren, K. ; Voce, A. ; Margot, B. ; Reddy, T. ; Master, I. ; Brust, James C.M. ; Chaiyachati, K. ; Padayatchi, N. / Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa. In: International Journal of Tuberculosis and Lung Disease. 2012 ; Vol. 16, No. 2. pp. 209-215.
@article{ad96517b2cbf4102a83c7068600302f4,
title = "Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa",
abstract = "SETTING: In KwaZulu-Natal, South Africa, a setting endemic for tuberculosis (TB) and the human immunodeficiency virus (HIV), prolonged hospitalisation for the treatment of the growing number of multidrug-resistant TB (MDR-TB) patients is neither possible nor effective. OBJECTIVE: To compare early treatment outcomes in patients with MDR-TB with and without HIV coi nfection at four decentralised rural sites with a central urban referral hospital. DESIGN: This is an operational, prospective cohort study of patients between 1 July 2008 and 30 November 2009, where culture conversion, time to culture conversion, survival and predictors of these outcomes were analysed. RESULTS: Of 860 patients with MDR-TB, 419 were at the decentralised sites and 441 at the central hospital. Overall, 71{\%} were HIV co-infected. In the 17-month study period, there was a higher proportion of culture conversion at the decentralised sites compared with the centralised hospital (54{\%} vs. 24{\%}, P < 0.001, OR 3.76, 95{\%}CI 2.81-5.03). The median time to treatment initiation was significantly shorter at the decentralised sites compared with the centralised hospital (72 vs. 93 days, P < 0.001). There was no significant difference in survival following treatment initiation. CONCLUSION: In this study, early treatment outcomes suggest that decentralised care for MDR-TB patients is superior to that in a centralised setting.",
keywords = "High burden of TB and HIV, Operational research",
author = "Marian Loveday and K. Wallengren and A. Voce and B. Margot and T. Reddy and I. Master and Brust, {James C.M.} and K. Chaiyachati and N. Padayatchi",
year = "2012",
month = "2",
day = "1",
doi = "10.5588/ijtld.11.0401",
language = "English (US)",
volume = "16",
pages = "209--215",
journal = "International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "International Union against Tubercul. and Lung Dis.",
number = "2",

}

TY - JOUR

T1 - Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa

AU - Loveday, Marian

AU - Wallengren, K.

AU - Voce, A.

AU - Margot, B.

AU - Reddy, T.

AU - Master, I.

AU - Brust, James C.M.

AU - Chaiyachati, K.

AU - Padayatchi, N.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - SETTING: In KwaZulu-Natal, South Africa, a setting endemic for tuberculosis (TB) and the human immunodeficiency virus (HIV), prolonged hospitalisation for the treatment of the growing number of multidrug-resistant TB (MDR-TB) patients is neither possible nor effective. OBJECTIVE: To compare early treatment outcomes in patients with MDR-TB with and without HIV coi nfection at four decentralised rural sites with a central urban referral hospital. DESIGN: This is an operational, prospective cohort study of patients between 1 July 2008 and 30 November 2009, where culture conversion, time to culture conversion, survival and predictors of these outcomes were analysed. RESULTS: Of 860 patients with MDR-TB, 419 were at the decentralised sites and 441 at the central hospital. Overall, 71% were HIV co-infected. In the 17-month study period, there was a higher proportion of culture conversion at the decentralised sites compared with the centralised hospital (54% vs. 24%, P < 0.001, OR 3.76, 95%CI 2.81-5.03). The median time to treatment initiation was significantly shorter at the decentralised sites compared with the centralised hospital (72 vs. 93 days, P < 0.001). There was no significant difference in survival following treatment initiation. CONCLUSION: In this study, early treatment outcomes suggest that decentralised care for MDR-TB patients is superior to that in a centralised setting.

AB - SETTING: In KwaZulu-Natal, South Africa, a setting endemic for tuberculosis (TB) and the human immunodeficiency virus (HIV), prolonged hospitalisation for the treatment of the growing number of multidrug-resistant TB (MDR-TB) patients is neither possible nor effective. OBJECTIVE: To compare early treatment outcomes in patients with MDR-TB with and without HIV coi nfection at four decentralised rural sites with a central urban referral hospital. DESIGN: This is an operational, prospective cohort study of patients between 1 July 2008 and 30 November 2009, where culture conversion, time to culture conversion, survival and predictors of these outcomes were analysed. RESULTS: Of 860 patients with MDR-TB, 419 were at the decentralised sites and 441 at the central hospital. Overall, 71% were HIV co-infected. In the 17-month study period, there was a higher proportion of culture conversion at the decentralised sites compared with the centralised hospital (54% vs. 24%, P < 0.001, OR 3.76, 95%CI 2.81-5.03). The median time to treatment initiation was significantly shorter at the decentralised sites compared with the centralised hospital (72 vs. 93 days, P < 0.001). There was no significant difference in survival following treatment initiation. CONCLUSION: In this study, early treatment outcomes suggest that decentralised care for MDR-TB patients is superior to that in a centralised setting.

KW - High burden of TB and HIV

KW - Operational research

UR - http://www.scopus.com/inward/record.url?scp=84855693356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855693356&partnerID=8YFLogxK

U2 - 10.5588/ijtld.11.0401

DO - 10.5588/ijtld.11.0401

M3 - Article

VL - 16

SP - 209

EP - 215

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

SN - 1027-3719

IS - 2

ER -